Trials / Unknown
UnknownNCT01860144
An Observational Study of Bevacizumab in Chinese Patients With Metastatic Colorectal Cancer
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 250 (estimated)
- Sponsor
- Peking University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This observational, multicenter, prospective study will evaluate the use of bevacizumab in real clinical practice in chinese patients with metastatic colorectal cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bevacizumab |
Timeline
- Start date
- 2012-06-01
- Primary completion
- 2015-12-01
- Completion
- 2015-12-01
- First posted
- 2013-05-22
- Last updated
- 2015-05-19
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01860144. Inclusion in this directory is not an endorsement.